Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration

Pharmacokinetic/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations

(2016) Qianting Yang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients

(2016) Claire Roger et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure

(2015) Lisa C. Martial et al.   CLINICAL PHARMACOKINETICS

A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality

(2014) Matteo Bassetti et al.   INTENSIVE CARE MEDICINE

Pharmacokinetics of caspofungin in ICU patients

(2014) E. W. Muilwijk et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis

(2013) Gudrun Würthwein et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Caspofungin in Critically Ill Patients on Continuous Renal Replacement Therapy

(2013) Stefan Weiler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian

(2013) Tatiana Tatarinova et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control

(2012) M. Kollef et al.   CLINICAL INFECTIOUS DISEASES

Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R

(2012) Michael N. Neely et al.   THERAPEUTIC DRUG MONITORING

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration

(2011) J. M. Leitner et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes

(2011) S. A. Grim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

(2010) D. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Echinocandin pharmacodynamics: review and clinical implications

(2010) M. W. Pound et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants

(2010) Elizabeth M. Migoya et al.   JOURNAL OF CLINICAL PHARMACOLOGY

A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis

(2009) Robert F. Betts et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic issues for antibiotics in the critically ill patient

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Principles of antibacterial dosing in continuous renal replacement therapy

(2009) Gordon Choi et al.   CRITICAL CARE MEDICINE

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION